Syphilis and HIV Infection: an Update

Dermatologic Clinics

Volumn 24, Issue 4, 2006, Pages 497-507

  Stevenson, Jill ^a   Heath, Michelle ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; BENZATHINE PENICILLIN; CEFTRIAXONE; DOXYCYCLINE; MACROLIDE; PENICILLIN G;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANDIDIASIS; CLINICAL FEATURE; CLINICAL TRIAL; GENITAL ULCER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOPLAKIA; NEUROSYPHILIS; ORAL SEXUAL CONTACT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SECONDARY SYPHILIS; SYPHILIS; TREPONEMA PALLIDUM;

HIV INFECTIONS; HUMANS; SYPHILIS;

EID: 33749166382     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2006.06.013     Document Type: Review

References (105)

1. Ross J.J. Shakespeare's chancre: did the bard have syphilis?. Clin Infect Dis 40 (2005) 399-404
2. Cohen J., and Powderly W. Infectious diseases. 2nd edition (2004), Mosby, Philadelphia
3. Chesson H.W., Pinkerton S.D., Voigt R., et al. HIV infections and associated costs attributable to syphilis coinfection among African Americans. Am J Public Health 93 6 (2003) 943-948
4. Buchacz K., Patel P., Taylor M., et al. Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS 18 15 (2004) 2075-2079
5. Buckley H.B. Syphilis: a review and update of this 'new' infection of the '90s. Nurse Pract 17 8 (1992) 25, 29-32
6. Department of Health and Human Services Center For Disease Control and Prevention. Sexually transmitted diseases, syphilis. Available at: www.cdc.gov/std/Syphilis. Accessed September 1, 2005.
7. Chesson H.W., Dee T.S., and Aral S.O. AIDS mortality may have contributed to the decline in syphilis rates in the United States in the 1990s. Sex Transm Dis 30 5 (2003) 419-424
8. Simms I., Fenton K.A., Ashton M., et al. The re-emergence of syphilis in the United Kingdom: the new epidemic phases. Sex Transm Dis 32 4 (2005) 220-226
9. Fenton K.A., and Imrie J. Increasing rates of sexually transmitted diseases in homosexual men in Western Europe and the United States: why?. Infect Dis Clin North Am 19 2 (2005) 311-331
10. Couturier E., Michel A., Janier M., et al. Syphilis surveillance in France, 2000-2003. Euro Surveill 9 12 (2004) 8-10
11. Schofer H. [Syphilis treatment. German and international guidelines-a comparison]. Hautarzt 56 2 (2005) 141-150 [in German]
12. AIDS epidemic update. 2005. World Health Department of HIV/AIDS; 2005. Available at: http://www.unaids.org/epi/2005/doc/EPIupdate2005_html_en/epi05_00_en.htm . Accessed January 1, 2006.
13. Wong W., Chaw J.K., Kent C.K., et al. Risk factors for early syphilis among gay and bisexual men seen in an STD clinic: San Francisco, 2002-2003. Sex Transm Dis 32 7 (2005) 458-463
14. Internet use and early syphilis infection among men who have sex with men-San Francisco, California, 1999-2003. MMWR Morb Mortal Wkly Rep 52 50 (2003) 1229-1232
15. Scott C.M., and Flint S.R. Oral syphilis-re-emergence of an old disease with oral manifestations. Int J Oral Maxillofac Surg 34 1 (2005) 58-63
16. Alam F., Argiriadou A.S., Hodgson T.A., et al. Primary syphilis remains a cause of oral ulceration. Br Dent J 189 7 (2000) 352-354
17. Lynn W.A., and Lightman S. Syphilis and HIV: a dangerous combination. Lancet Infect Dis 4 7 (2004) 456-466
18. Rompalo A.M., Joesoef M.R., O'Donnell J.A., et al. Clinical manifestations of early syphilis by HIV status and gender: results of the syphilis and HIV study. Sex Transm Dis 28 3 (2001) 158-165
19. Rompalo A.M., Lawlor J., Seaman P., et al. Modification of syphilitic genital ulcer manifestations by coexistent HIV infection. Sex Transm Dis 28 8 (2001) 448-454
20. Nnoruka E.N., and Ezeoke A.C. Evaluation of syphilis in patients with HIV infection in Nigeria. Trop Med Int Health 10 1 (2005) 58-64
21. Inamadar A.C., and Palit A. Perforating chancre: any cause-effect relation with HIV infection?. Sex Transm Infect 79 3 (2003) 262
22. Behets F.M., Liomba G., Lule G., et al. Sexually transmitted diseases and human immunodeficiency virus control in Malawi: a field study of genital ulcer disease. J Infect Dis 171 2 (1995) 451-455
23. Fleming D.T., and Wasserheit J.N. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 75 1 (1999) 3-17
24. Lukehart S.A., Godornes C., Molini B.J., et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 351 2 (2004) 154-158
25. Clark E.G., and Danbolt N. The Oslo study of the natural history of untreated syphilis; an epidemiologic investigation based on a restudy of the Boeck-Bruusgaard material; a review and appraisal. J Chronic Dis 2 3 (1955) 311-344
26. Zeltser R., and Kurban A.K. Syphilis. Clin Dermatol 22 6 (2004) 461-468
27. Freedburg I., Eisen A., Wolfe K., et al. Fitzpatrick's dermatology in general medicine. 6th edition (2003), McGraw-Hill, New York
28. Czelusta A., Yen-Moore A., Van der Straten M., et al. An overview of sexually transmitted diseases. Part III. Sexually transmitted diseases in HIV-infected patients. J Am Acad Dermatol 43 3 (2000) 409-432 [quiz: 433-6]
29. Ivens D., and Patel M. Incidence and presentation of early syphilis diagnosed in HIV-positive gay men attending a central London outpatients' department. Int J STD AIDS 16 3 (2005) 201-202
30. Hutchinson C.M., Hook III E.W., Shepherd M., et al. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med 121 2 (1994) 94-100
31. Golden M.R., Marra C.M., and Holmes K.K. Update on syphilis: resurgence of an old problem. JAMA 290 11 (2003) 1510-1514
32. Little J.W. Syphilis: an update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 100 1 (2005) 3-9
33. Lu S.Y., and Eng H.L. Secondary syphilis-related oral ulcers: report of four cases. Chang Gung Med J 25 10 (2002) 683-688
34. Aquilina C., Viraben R., and Denis P. Secondary syphilis simulating oral hairy leukoplakia. J Am Acad Dermatol 49 4 (2003) 749-751
35. Passoni L.F., de Menezes J.A., Ribeiro S.R., et al. Lues maligna in an HIV-infected patient. Rev Soc Bras Med Trop 38 2 (2005) 181-184
36. Romero-Jimenez M.J., Suarez Lozano I., Fajardo Pico J.M., et al. [Malignant syphilis in patient with human immunodeficiency virus (HIV): case report and literature review]. An Med Interna 20 7 (2003) 373-376 [in Spanish]
37. Fisher D.A., Chang L.W., and Tuffanelli D.L. Lues maligna. Presentation of a case and a review of the literature. Arch Dermatol 99 1 (1969) 70-73
38. Rosenheim M., Brucker G., Leibowitch M., et al. [Malignant syphilis in a patient with anti-HIV antibodies]. Presse Med 16 16 (1987) 777 [in French]
39. Burdette S.D., Waibel J.S., Bernstein J.M., et al. With this eruption, there is not a second to lues. Skinmed 4 3 (2005) 179-182
40. D'Amico R., and Zalusky R. A case of lues maligna in a patient with acquired immunodeficiency syndrome (AIDS). Scand J Infect Dis 37 9 (2005) 697-700
41. Watson K.M., White J.M., Salisbury J.R., et al. Lues maligna. Clin Exp Dermatol 29 6 (2004) 625-627
42. Sands M., and Markus A. Lues maligna, or ulceronodular syphilis, in a man infected with human immunodeficiency virus: case report and review. Clin Infect Dis 20 2 (1995) 387-390
43. De Rie M.A., Mekkes J.R., Cohen E.B., et al. Syphilis maligna: a HIV-related problem?. Br J Dermatol 125 4 (1991) 390-391
44. Schofer H., Imhof M., Thoma-Greber E., et al. Active syphilis in HIV infection: a multicentre retrospective survey. The German AIDS Study Group (GASG). Genitourin Med 72 3 (1996) 176-181
45. Kiss S., Damico F.M., and Young L.H. Ocular manifestations and treatment of syphilis. Semin Ophthalmol 20 3 (2005) 161-167
46. Spoor T.C., Ramocki J.M., Nesi F.A., et al. Ocular syphilis 1986. Prevalence of FTA-ABS reactivity and cerebrospinal fluid findings. J Clin Neuroophthalmol 7 4 (1987) 191-5, 196-197
47. Doris J.P., Saha K., Jones N.P., et al. Ocular syphilis: the new epidemic. Eye Jun (2005) 3
48. Musher D.M., Hamill R.J., and Baughn R.E. Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med 113 11 (1990) 872-881
49. Aldave A.J., King J.A., and Cunningham Jr. E.T. Ocular syphilis. Curr Opin Ophthalmol 12 6 (2001) 433-441
50. Tran T.H., Cassoux N., Bodaghi B., et al. Syphilitic uveitis in patients infected with human immunodeficiency virus. Graefes Arch Clin Exp Ophthalmol 243 9 (2005) 863-869
51. Fournier S., Deplus S., Janier M., et al. [Anterior uveitis in HIV-infected patients. 3 cases in patients treated with an antiprotease]. Presse Med 27 18 (1998) 844-848 [in French]
52. Thami G.P., Kaur S., Gupta R., et al. Syphilitic panuveitis and asymptomatic neurosyphilis: a marker of HIV infection. Int J STD AIDS 12 11 (2001) 754-756
53. Cohen C.E., Winston A., Asboe D., et al. Increasing detection of asymptomatic syphilis in HIV patients. Sex Transm Infect 81 3 (2005) 217-219
54. Sena A.C., Mertz K.J., Thomas D., et al. A survey of sexually transmitted diseases/HIV coinfection testing and reporting practices among health care providers in New Jersey. Sex Transm Dis 32 7 (2005) 406-412
55. Regal L., Demaerel P., and Dubois B. Cerebral syphilitic gumma in a human immunodeficiency virus-positive patient. Arch Neurol 62 8 (2005) 1310-1311
56. Katz D.A., Berger J.R., and Duncan R.C. Neurosyphilis. A comparative study of the effects of infection with human immunodeficiency virus. Arch Neurol 50 3 (1993) 243-249
57. Lana-Peixoto M.A., Teixeira Jr. A.L., Tzelikis P.F., et al. Asymptomatic intracranial gumma in a patient with syphilitic uveitis and human immunodeficiency virus infection. Scand J Infect Dis 35 5 (2003) 343-345
58. Jackman Jr. J.D., and Radolf J.D. Cardiovascular syphilis. Am J Med 87 4 (1989) 425-433
59. Peters J.J., Peers J.H., Olansky S., et al. Untreated syphilis in the male Negro; pathologic findings in syphilitic and nonsyphilitic patients. J Chronic Dis 1 2 (1955) 127-148
60. Rosahn P. Autopsy studies in syphilis (1950), US Department of Health, Education, and Welfare, Public Health Service, Centers for Disease Control and Prevention, Atlanta (GA)
61. Bleeker-Rovers C.P., van der Ven A.J., Zomer B., et al. F-18-fluorodeoxyglucose positron emission tomography for visualization of lipodystrophy in HIV-infected patients. AIDS 18 18 (2004) 2430-2432
62. Sinzobahamvya N., Kalangu K., and Hamel-Kalinowski W. Arterial aneurysms associated with human immunodeficiency virus (HIV) infection. Acta Chir Belg 89 4 (1989) 185-188
63. Chetty R., Batitang S., and Nair R. Large artery vasculopathy in HIV-positive patients: another vasculitic enigma. Hum Pathol 31 3 (2000) 374-379
64. Olmos J.M., Fernandez-Ayala M., Gutierrez J.A., et al. Superior vena cava syndrome secondary to syphilitic aneurysm of the ascending aorta in a human immunodeficiency virus-infected patient. Clin Infect Dis 27 5 (1998) 1331-1332
65. Maharajan M., and Kumaar G.S. Cardiovascular syphilis in HIV infection: a case-control study at the Institute of Sexually Transmitted Diseases, Chennai, India. Sex Transm Infect 81 4 (2005) 361
66. Lukehart S.A., Hook III E.W., Baker-Zander S.A., et al. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med 109 11 (1988) 855-862
67. Rolfs R.T., Joesoef M.R., Hendershot E.F., et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study Group. N Engl J Med 337 5 (1997) 307-314
68. Marra C.M. Neurosyphilis. Curr Neurol Neurosci Rep 4 6 (2004) 435-440
69. Bordon J., Martinez-Vazquez C., Alvarez M., et al. Neurosyphilis in HIV-infected patients. Eur J Clin Microbiol Infect Dis 14 10 (1995) 864-869
70. Johns D.R., Tierney M., and Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med 316 25 (1987) 1569-1572
71. de Souza M.C., and Nitrini R. Effects of human immunodeficiency virus infection on the manifestations of neurosyphilis. Neurology 49 3 (1997) 893-894
72. Musher D.M. Syphilis, neurosyphilis, penicillin, and AIDS. J Infect Dis 163 6 (1991) 1201-1206
73. Berry C.D., Hooton T.M., Collier A.C., et al. Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med 316 25 (1987) 1587-1589
74. Ito F., Hunter E.F., George R.W., et al. Specific immunofluorescence staining of Treponema pallidum in smears and tissues. J Clin Microbiol 29 3 (1991) 444-448
75. Palmer H.M., Higgins S.P., Herring A.J., et al. Use of PCR in the diagnosis of early syphilis in the United Kingdom. Sex Transm Infect 79 6 (2003) 479-483
76. Hart G. Syphilis tests in diagnostic and therapeutic decision making. Ann Intern Med 104 3 (1986) 368-376
77. Larsen S.A. Syphilis. Clin Lab Med 9 3 (1989) 545-557
78. Nandwani R. Modern diagnosis and management of acquired syphilis. Br J Hosp Med 55 7 (1996) 399-403
79. Hicks C.B., Benson P.M., Lupton G.P., et al. Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma. A diagnostic dilemma. Ann Intern Med 107 4 (1987) 492-495
80. Tikjob G., Russel M., Petersen C.S., et al. Seronegative secondary syphilis in a patient with AIDS: identification of Treponema pallidum in biopsy specimen. J Am Acad Dermatol 24 3 (1991) 506-508
81. Kingston A.A., Vujevich J., Shapiro M., et al. Seronegative secondary syphilis in 2 patients coinfected with human immunodeficiency virus. Arch Dermatol 141 4 (2005) 431-433
82. Blum L., Bachmeyer C., and Caumes E. Seronegative secondary syphilis in an HIV-infected patient. Clin Exp Dermatol 30 2 (2005) 158-159
83. Drabick J.J., and Tramont E.C. Utility of the VDRL test in HIV-seropositive patients. N Engl J Med 322 4 (1990) 271
84. Sordillo E.M., Hoehl B., and Belch J. False-negative fluorescent treponemal tests and confirmation of syphilis infection. J Infect Dis 178 1 (1998) 294-295
85. Fowler Jr. V.G., Maxwell G.L., Myers S.A., et al. Failure of benzathine penicillin in a case of seronegative secondary syphilis in a patient with acquired immunodeficiency syndrome: case report and review of the literature. Arch Dermatol 137 10 (2001) 1374-1376
86. Jurado R.L., Campbell J., and Martin P.D. Prozone phenomenon in secondary syphilis. Has its time arrived?. Arch Intern Med 153 21 (1993) 2496-2498
87. Taniguchi S., Osato K., and Hamada T. The prozone phenomenon in secondary syphilis. Acta Derm Venereol 75 2 (1995) 153-154
88. Haslett P., and Laverty M. The prozone phenomenon in syphilis associated with HIV infection. Arch Intern Med 154 14 (1994) 1643-1644
89. Malone J.L., Wallace M.R., Hendrick B.B., et al. Syphilis and neurosyphilis in a human immunodeficiency virus type-1 seropositive population: evidence for frequent serologic relapse after therapy. Am J Med 99 1 (1995) 55-63
90. Smikle M.F., James O.B., and Prabhakar P. Biological false positive serological tests for syphilis in the Jamaican population. Genitourin Med 66 2 (1990) 76-78
91. Rompalo A.M., Cannon R.O., Quinn T.C., et al. Association of biologic false-positive reactions for syphilis with human immunodeficiency virus infection. J Infect Dis 165 6 (1992) 1124-1126
92. Marra C.M., Maxwell C.L., Smith S.L., et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 189 3 (2004) 369-376
93. Weedon D. Skin pathology. 2nd edition (2002), Churchill Livingstone, New York
94. Carbia S.G., Lagodin C., and Abbruzzese M. Lichenoid secondary syphilis. Int J Dermatol 38 (1999) 53-55
95. Buchacz K., Greenberg A., Onorato I., et al. Syphilis epidemics and human immunodeficiency virus (HIV) incidence among men who have sex with men in the United States: implications for HIV prevention. Sex Transm Dis 32 10 Suppl (2005) S73-S79
96. Jordan H.F., and Cilliers J. Secondary syphilis mimicking Sweet's syndrome. Br J Dermatol 115 (1986) 495-496
97. Magnuson H.J., Thomas E.W., Olansky S., et al. Inoculation syphilis in human volunteers. Medicine (Baltimore) 35 1 (1956) 33-82
98. Mahoney J.F., Arnold R.C., and Harris A. Penicillin treatment of early syphilis; first four patients after 6 years. J Vener Dis Inf 30 12 (1949) 350-355
99. Smith C.A., Kamp M., Olansky S., et al. Benzathine penicillin G in the treatment of syphilis. Bull World Health Organ 15 6 (1956) 1087-1096
100. Bryceson A.D. Clinical pathology of the Jarisch-Herxheimer reaction. J Infect Dis 133 6 (1976) 696-704
101. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 51 RR-6 (2002) 1-78
102. Brown S.T., Zaidi A., Larsen S.A., et al. Serological response to syphilis treatment. A new analysis of old data. JAMA 253 9 (1985) 1296-1299
103. Schroeter A.L., Lucas J.B., Price E.V., et al. Treatment for early syphilis and reactivity of serologic tests. JAMA 221 5 (1972) 471-476
104. Yinnon A.M., Coury-Doniger P., Polito R., et al. Serologic response to treatment of syphilis in patients with HIV infection. Arch Intern Med 156 3 (1996) 321-325
105. Riedner G., Rusizoka M., Todd J., et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl J Med 353 12 (2005) 1236-1244